US OptionsDetailed Quotes
RIGL250117C18000
- 0.70
- 0.000.00%
15min DelayClose Jan 7 16:00 ET
0.00High0.00Low
0.70Open0.70Pre Close0 Volume3 Open Interest18.00Strike Price0.00Turnover97.34%IV9.42%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.70Extrinsic Value100Contract SizeAmericanOptions Type0.4019Delta0.1454Gamma20.72Leverage Ratio-0.0572Theta0.0016Rho8.33Eff Leverage0.0106Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
No comment yet